Quality of the Cardio-pulmonary Resuscitation

February 10, 2022 updated by: Tampere University Hospital

Cardiopulmonary Resuscitation; Epidemiology, Quality, Survival and Injuries.

Patients having sudden cardiac arrest have very poor prognosis. It is devastating for patient and family. But also very expensive for nations economics when working-age people die or disable due to cardiac arrest. Recent studies have shown that high quality of cardiopulmonary resuscitation (CPR) and minimized delays increases the survival after cardiac arrest. In this objective prospective study we will use Zoll´s X Series defibrillator on every emergency medicine systems (EMS´s) unit in Pirkanmaa area, Finland, to collect information on CPR quality. Real CPR Help® will collect the information on depth, frequency and pauses during CPR. We will make an Utstein analysis on OHCA during one year period and compare the results on Utstein analysis made in the same area on 2013-2014. We will analyse the quality of CPR and compare it to the outcome from OHCA and neurological outcome 3 months after resuscitation. In addition we will analyse the CPR related injuries and compare these to the compression depth and number of persons performing CPR.

In one part of the study we will evaluate the incidence of OHCA in different risk areas of Pirkanmaa and analyse the influence of time delay and location to the outcome out of hospital and neurological outcome 3 months after resuscitation. We will also analyse if the time of post-resuscitation care before getting to the hospital or stenosis in carotid artery affects the outcome from OHCA and neurological outcome 3 months after resuscitation.

Study Overview

Status

Recruiting

Study Type

Observational

Enrollment (Anticipated)

400

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

      • Tampere, Finland, 33521
        • Recruiting
        • Tampere University Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 100 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

All cardiac arrest patients in Etelä-Pohjanmaa and Pirkanmaa, Finland

Description

Inclusion Criteria:

  • cardiac arrest
  • > 18 years of age

Exclusion Criteria:

  • < 18 years of age
  • prisoners

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Cardiac arrest
All patients having sudden cardiac arrest out-of-hospital in Pirkanmaa, Finland
ResusInj
OHCA survivors having CPR related injuries or carotid stenosis analyzed by CT
ResusCPC
OHCA survivors neurological outcome

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
QualityCPR
Time Frame: 1 year
The success rate of current guidelines (depth and frequency of chest compression, epidemiology)
1 year
Neurological survival after CA
Time Frame: 3 months after OHCA
Neurological survival after CA
3 months after OHCA

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
CPR related injuries
Time Frame: 1 year
Injuries detected in CT scanning or in autopsy
1 year
Stenosis of the carotid artery
Time Frame: 3 months after OHCA
Effect of the carotid artery stenosis to the neurological survival. Survivals having CPC 1-2 prior to the cardiac arrest and are taken to the ICU are scanned with carotid CTA after informed consent. The degree of stenosis will be compared to the CPC-level 3monts aften OHCA.
3 months after OHCA
the dispatch calls concerning OHCA
Time Frame: 1 year

Analyze the key words and dispatch assisted CPR through the emergency call. All emergency call conserning OHCA patients will be listened. We will analyze the keywords which are used by layperson to describe patient having cardiac arrest.

We will also analyze the amount of given dispatch assisted CPR and compare the amount to the primary rythm.

1 year
the quality of the postresuscitation care
Time Frame: 3 months after OHCA
The correlation of the duration and the quality of the postresuscitation care before getting in to the hospital and the outcome from OHCA
3 months after OHCA

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Piritta Setälä, PhD, Tampere University Hospital
  • Study Director: Sanna Hoppu, PhD, Tampere University Hospital
  • Principal Investigator: Jyrki Ollikainen, MD, Tampere University Hospital
  • Study Director: Kati Järvelä, PhD, Tampere University Hospital
  • Principal Investigator: Valtteri Järvenpää, MB, Tampere University Hospital
  • Study Director: Ville Jalkanen, PhD, Tampere University Hospital
  • Study Director: Joonas Tirkkonen, PhD, Tampere University Hospital
  • Study Director: Heini Huhtala, PhD, Tampere University
  • Study Director: Mika Martiskainen, PhD, Finnish Institute for Health and Welfare
  • Study Director: Riikka Nevalainen, MD, Tampere University Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

January 1, 2022

Primary Completion (ANTICIPATED)

March 31, 2023

Study Completion (ANTICIPATED)

July 1, 2023

Study Registration Dates

First Submitted

January 3, 2022

First Submitted That Met QC Criteria

February 10, 2022

First Posted (ACTUAL)

February 22, 2022

Study Record Updates

Last Update Posted (ACTUAL)

February 22, 2022

Last Update Submitted That Met QC Criteria

February 10, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • R18100
  • R18163 (REGISTRY: ResusciCPC)
  • R21124 (REGISTRY: ResusciCT)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Cardiopulmonary Resuscitation

3
Subscribe